





View the conference flyer (
469 KB).
Jim McKiernan
Conference Co-Chair
CEO McKiernan Associates
Esther Sadler-Williams
Conference Co-Chair
Catalent
Chedia Abdelkafi
Head of Global CTS Planning
UCB Pharma
Key themes and their implications for IP professionals will be explored in-depth.
These include: JIT labelling and pooling to optimise the clinical supply chain, supply chain security and
recommendations for improving the management of supplies from a clinical site perspective.
Industry and regulatory experts will share and network with delegates to maximise the learning
experience.
Status and initial findings of the ISPE IP COP survey on the Patient Experiences with IP will be introduced
during the event.
Discussions surrounding solutions in cold chain management as well as control equipment choice and good practices to make your supply chain commercially viable and solid will be featured.
Delegates will gain insights into anti-counterfeiting issues, packaging fraud, pharmacovigilance and
effective recall.
The new legalities around falsified medicines and new obligations for manufacturers and distributors of
medicinal products will be covered by an MHRA, Expert GMP / GDP Inspector.
European regulators will discuss GMP Guidelines and upcoming Directives.
View the full conference agenda.
Thank you to our Top Tier Sponsors
Follow ISPE